Rheumatoid arthritis: The goal rather than the health-care provider is key

Lancet

Volumn 367, Issue 9509, 2006, Pages 450-452

  Vencovský, Jiří ^a   Huizinga, Tom W J ^b  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

COST EFFECTIVENESS ANALYSIS; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; HEALTH CARE; HUMAN; INTERVIEW; NOTE; NURSING; ONSET AGE; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

EID: 32144445922     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68154-3     Document Type: Note

References (11)

1. FM McQueen, N Stewart, J Crabbe Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset Ann Rheum Dis 57 1998 350 356
2. JS Smolen, D Aletaha, KP Machold Therapeutic strategies in early rheumatoid arthritis Best Pract Res Clin Rheumatol 19 2005 163 177
3. J van Aken, LR Lard, S le Cessie, JM Hazes, FC Breedveld, TW Huizinga Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis Ann Rheum Dis 63 2004 274 279
4. C Grigor, H Capell, A Stirling Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial Lancet 364 2004 263 269
5. YP Goekoop-Ruiterman, JK de Vries-Bouwstra, CF Allaart Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial Arthritis Rheum 52 2005 3381 3390
6. D Symmons, K Tricker, C Roberts, L Davies, P Dawes, DL Scott The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis Health Technol Assess 9 2005 iii-78
7. L Klareskog, D van der Heijde, JP de Jager for the TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial Lancet 363 2004 675 681
8. F Wolfe, JT Sharp Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression Arthritis Rheum 41 1998 1571 1582
9. Hulsmans HMJ, Jacobs JWG, van der Heijde DMFM, GA van Albada-Kuipers, Y Schenk, Bijlsma JWJ The course of radiologic damage during the first six years of rheumatoid arthritis Arthritis Rheum 43 2000 1927 1940
10. AE Clarke, Y St-Pierre, L Joseph, JT Penrod, MH Sibley, HK Genant Radiographic damage in rheumatoid arthritis correlates with functional disability but not the direct medical cost J Rheumatol 28 2001 2416 2424
11. Welsing PMJ, Landewé RBM, van Riel PLCM The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis Arthritis Rheum 50 2004 2082 2093